Burning Rock Biotech (BNR) Notes Payables (2019 - 2025)

Burning Rock Biotech's Notes Payables history runs 5 years deep, the most recent figure standing at $28000.0 for Q3 2025.

• In Q3 2025, Notes Payables changed N/A year-over-year to $28000.0; the TTM figure through Sep 2025 stood at $28000.0 (changed N/A YoY), while the FY2021 annual figure was $344000.0, down 7.53% from the prior year.
• Notes Payables was $28000.0 for Q3 2025 at Burning Rock Biotech, down from $354000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $1.1 million in Q3 2021 to a low of $28000.0 in Q3 2025.
• Historically, Notes Payables has averaged $648098.7 across 3 years, with a median of $374000.0 in 2022.
• The sharpest annual moves came in 2021 and 2022: Notes Payables soared 240.6% in 2021, then slumped 68.97% in 2022.
• A 3-year view of Notes Payables shows it stood at $370690.7 in 2021, then dropped by 4.5% to $354000.0 in 2022, then sank by 92.09% to $28000.0 in 2025.
• The last three Notes Payables figures came in at $28000.0 (Q3 2025), $354000.0 (Q2 2022), and $374000.0 (Q1 2022), per Business Quant data.